MARKET

ANEB

ANEB

Anebulo Pharmaceuticals Inc
NASDAQ
1.630
+0.200
+13.99%
Opening 12:45 03/14 EDT
OPEN
1.400
PREV CLOSE
1.430
HIGH
1.660
LOW
1.400
VOLUME
9.81K
TURNOVER
0
52 WEEK HIGH
3.300
52 WEEK LOW
0.8001
MARKET CAP
66.97M
P/E (TTM)
-5.6091
1D
5D
1M
3M
1Y
5Y
1D
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga · 23h ago
Weekly Report: what happened at ANEB last week (0303-0307)?
Weekly Report · 4d ago
ANEBULO PHARMACEUTICALS INC FILES FOR RESALE OF UP TO 15.15 MLN SHARES BY THE SELLING STOCKHOLDERS - SEC FILING
Reuters · 03/03 21:01
Weekly Report: what happened at ANEB last week (0224-0228)?
Weekly Report · 03/03 11:35
Analysts Conflicted on These Healthcare Names: Anebulo Pharmaceuticals (ANEB) and AMN Healthcare Services (AMN)
TipRanks · 02/25 12:30
Weekly Report: what happened at ANEB last week (0217-0221)?
Weekly Report · 02/24 11:34
Anebulo Pharmaceuticals files to sell 15.15M shares of common stock for holders
Seeking Alpha · 02/21 13:02
ANEBULO PHARMACEUTICALS INC FILES PROSPECTUS RELATED TO RESALE OF 15.2 MLN SHARES OF COMMON STOCK BY SELLING STOCKHOLDERS- SEC FILING
Reuters · 02/20 22:26
More
About ANEB
More
Anebulo Pharmaceuticals, Inc. is a clinical-stage biotechnology company. It is engaged in developing treatments for cannabis toxicity, such as unintentional cannabis poisoning, acute cannabinoid intoxication (ACI) and the landscape of acute cannabis-induced conditions. Its lead product candidate is selonabant, a potent, small molecule antagonist of cannabinoid binding receptor type-1 (CB1), the primary receptor involved in the psychotropic effects of cannabinoids, with the potential to address the unmet medical need for a therapy to treat cannabis toxicity. Selonabant is orally bioavailable, rapidly absorbed, and has also been formulated for intravenous treatment. Selonabant has completed dosing in a Phase II clinical trial evaluating its utility in blocking and reversing the negative effects of acute cannabinoid intoxication. It is also prioritizing the advancement of a selonabant IV formulation as a potential treatment for pediatric patients with unintentional cannabis poisoning.
Recently
Symbol
Price
%Change

Webull offers Anebulo Pharmaceuticals Inc stock information, including NASDAQ: ANEB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ANEB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ANEB stock methods without spending real money on the virtual paper trading platform.